Navigation Links
PharmAthene Secures $7.5 Million Credit Facility From GE Capital, Healthcare Financial Services
Date:4/3/2012

"; "will"; "project"; "potential"; or similar statements are forward-looking statements.  PharmAthene disclaims any intent or obligation to update these forward-looking statements other than as required by law.  Risks and uncertainties include risk associated with the reliability of the results of the studies relating to human safety and possible adverse effects resulting from the administration of the PharmAthene's product candidates, unexpected funding delays and/or reductions or elimination of U.S. government funding for one or more of the PharmAthene's development programs, the award of government contracts to our competitors, unforeseen safety issues, challenges related to the development, scale-up, technology transfer, and/or process validation of manufacturing processes for our product candidates, unexpected determinations that these product candidates prove not to be effective and/or capable of being marketed as products, as well as risks detailed from time to time in PharmAthene's Forms 10-K and 10-Q under the caption "Risk Factors" and in its other reports filed with the U.S. Securities and Exchange Commission.  In particular, there is significant uncertainty regarding the level and timing of sales of ST-246 and when and whether it will be approved by the U.S. FDA and corresponding health agencies around the world. Further, we cannot predict with certainty when SIGA Technologies, Inc. ("SIGA") will commence delivering any product or will begin recognizing profit on the sale of ST-246 and there can be no assurance that any profits received by SIGA and paid to PharmAthene will be significant.  We note that SIGA has publicly stated it intends to appeal the Court of Chancery decision, and there can be no assurances that the decision will not be reversed or that the remedy will not otherwise be modified. In addition, to the extent that there is an appeal, we cannot predict how long such appeal will delay the receipt of payments, if any, from
'/>"/>
SOURCE PharmAthene, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. PharmAthene to Present at the 24th Annual ROTH Conference on Monday, March 12, 2012
2. PharmAthene to Present at the Noble Financial Eighth Annual Equity Conference on Tuesday, January 17, 2012
3. PharmAthene Reports Third Quarter 2011 Financial and Operating Results
4. PharmAthene Progresses Second Generation rPA Anthrax Vaccine
5. PharmAthene Appoints Brian A. Markison to the Companys Board of Directors
6. PharmAthene Achieves Significant Progress in SparVax™ Anthrax Vaccine Program
7. Department of Defense Awards $5.7 Million Contract to PharmAthene for Nerve Agent Medical Countermeasure Program
8. PharmAthene Selected for Inclusion in the Russell Global Index and Russell 3000 Index
9. PharmAthene Achieves Anthrax Vaccine Program Milestone and Successfully Completes Technology Transfer
10. PharmAthene Completes $6.5 Million Registered Direct Offering
11. PharmAthene Reports First Quarter 2011 Financial and Operating Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... 27, 2014 “We are honored to ... said Ven Thangaraj, CEO of Radiant Sage. “We are ... taking the imaging corelab market to a different level. ... research organizations to efficiently and effectively manage the massive ... to be analyzed and read by trained physicians. Being ...
(Date:8/27/2014)... Research and Markets has announced ... & Paper Industry Report 2014" report to their ... & Paper Industry Report 2014 is a professional and ... enzyme for pulp & paper industry. The ... definitions, classifications, applications and industry chain structure. The enzyme ...
(Date:8/27/2014)... 27, 2014 Riviera Beach, Florida ... the creation of the Sancilio Scientific Advisory Board ... SCI’s philosophy of looking to nature for pharmaceutical ... actions are based on sound scientific data, analyses, ... Board provides a vehicle for SCI to receive ...
(Date:8/27/2014)... 2014 Remcom announces an update to ... features for the biomedical industry. The central biomedical ... Sensor, exclusive to the Bio-Pro version of the software. ... developed to calculate the biological effects of electromagnetic fields. ... to all versions to expand engineers’ post-processing options. , ...
Breaking Biology Technology:Radiant Sage Named to CIOReview List of 100 Most Promising Technology Companies 2Global Enzyme for Pulp & Paper Industry Report 2014 2New Sancilio & Company, Inc. Scientific Board 2New Sancilio & Company, Inc. Scientific Board 3Remcom Announces Enhanced Biological Thermal Sensor and Other Biomedical Features in XFdtd EM Simulation Software Update 2Remcom Announces Enhanced Biological Thermal Sensor and Other Biomedical Features in XFdtd EM Simulation Software Update 3
... While the great rock concert halls and rock festivals of ... these musical Meccas continues (mostly in the form of Farewell ... the wild 1980s and 1990s is celebrated every year in ... that lead the charge in promoting the hot biotech companies ...
... the first thing to do when draining a swamp is ... to an information swamp. Information not only needs to be ... also as its passed within an organization. IT shops are ... systems and even the old, back office systems running on ...
... organizations can increase their productivity and be more responsive ... the quality of the care they provide as a ... , a Hartford, Wis.-based software company. API Software announced ... Station (EIS) and its ActiveStaffer scheduling application, which recently ...
Cached Biology Technology:The Biotech Concert Halls of the Decade of 2000 2Draining the Information Swamp 2Draining the Information Swamp 3API Releases New Software, Acquires Additional Contracts 2
(Date:8/26/2014)... Animals (PETA) and the PETA International Science Consortium, LTD ... the 9th World Congress on Alternatives and Animal Use ... to the use of animals in research, testing and ... current laboratory oversight systems. , At the conference, which ... PETA and PISC will present seven oral and poster ...
(Date:8/25/2014)... has experienced widespread adoption of robot-assisted prostate removal ... The BJU International study also found ... traditional surgeries, their costs are decreasing over time. ... in operations to remove the prostate. To examine ... prostatectomy (RARP) procedures for prostate cancer patients, Steven ...
(Date:8/25/2014)... old saying in the biofuels industry: "You can ... a new study may pave the way to ... Department,s National Renewable Energy Laboratory (NREL) demonstrates a ... of lignin into a variety of renewable fuels, ... , " Lignin Valorization Through Integrated Biological Funneling ...
Breaking Biology News(10 mins):US has seen widespread adoption of robot-assisted cancer surgery to remove the prostate 2New process helps overcome obstacles to produce renewable fuels and chemicals 2
... international team of scientists, with Spanish participation, has shed ... documenting these acts for the first time in the ... cannot raise their infants without help from male group ... death of their offspring if they are stressed and ...
... singer hitting a note that shatters a glass, a ... in a material and change its properties. And as ... can change the critical pitch. Echoing both phenomena, researchers ... have demonstrated a unique fluid-tuned "metasurface," a concept that ...
... David Litchfield of The University of Western Ontario has ... cells to allow these cells to ignore,signals that should ... cancer cells may become resistant to therapy. The ... http://stke.sciencemag.org/cgi/content/full/sigtrans;4/172/ra30 ). "This work focused on understanding ...
Cached Biology News:Competition between females leads to infanticide in some primates 2NIST tunes 'metasurface' with fluid in new concept for sensing and chemistry 2
...
More cell-permeant than acridine orange....
Anti-rat Ig HRP detection kit...
One bottle containing 30 ml of protein solution and 0.1% sodium azide....
Biology Products: